Susquehanna International Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
80,500
-74,300
-48% -$2.44M ﹤0.01% 5895
2025
Q4
$5.79M Sell
154,800
-164,000
-51% -$5.39M ﹤0.01% 3792
2025
Q3
$8.79M Buy
318,800
+75,500
+31% +$2.6M ﹤0.01% 3204
2025
Q2
$7.69M Buy
243,300
+127,300
+110% +$4.1M ﹤0.01% 3232
2025
Q1
$3.85M Buy
116,000
+11,000
+10% +$394K ﹤0.01% 4151
2024
Q4
$3.61M Buy
105,000
+2,700
+3% +$92.8K ﹤0.01% 4117
2024
Q3
$4.09M Buy
102,300
+56,300
+122% +$1.98M ﹤0.01% 3960
2024
Q2
$1.39M Sell
46,000
-14,500
-24% -$436K ﹤0.01% 5833
2024
Q1
$2.03M Buy
60,500
+4,100
+7% +$132K ﹤0.01% 5304
2023
Q4
$1.82M Sell
56,400
-107,800
-66% -$3.01M ﹤0.01% 5568
2023
Q3
$5.38M Buy
164,200
+140,500
+593% +$4.88M ﹤0.01% 3393
2023
Q2
$834K Buy
23,700
+13,600
+135% +$470K ﹤0.01% 7111
2023
Q1
$330K Sell
10,100
-4,000
-28% -$182K ﹤0.01% 9503
2022
Q4
$777K Sell
14,100
-14,600
-51% -$803K ﹤0.01% 6738
2022
Q3
$1.27M Buy
28,700
+200
+0.7% +$9.76K ﹤0.01% 6014
2022
Q2
$1.39M Buy
+28,500
New +$1.28M ﹤0.01% 5730

Other funds holding HRMY

Susquehanna International Group's HRMY Position: Q1 2026 in Review

Susquehanna International Group increased its Harmony Biosciences (HRMY) stake by 248% in Q1 2026, buying an estimated $593K and bringing the position to 25,401 shares worth $711K. The position accounts for ﹤0.01% of the portfolio, ranked #8779.

Susquehanna International Group first reported a position in HRMY in Q1 2021 and has held it in 16 quarters since. The position peaked at $2.36M in Q2 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Susquehanna International Group held 25,401 shares of Harmony Biosciences worth $711K as of Q1 2026.
  • Susquehanna International Group bought 18,098 Harmony Biosciences shares in Q1 2026, an estimated $593K.
  • Harmony Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8779 holding.
  • Susquehanna International Group first reported a position in Harmony Biosciences in Q1 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Harmony Biosciences position peaked at $2.36M in Q2 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.